Viewing StudyNCT00475865



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00475865
Status: COMPLETED
Last Update Posted: 2012-11-06
First Post: 2007-05-18

Brief Title: Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Sponsor: Sanofi
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis
Keywords:
Name View
relapses View
MS View
glatiramer acetate View
adjunctive therapy View